Valneva SE is a biotechnology company focusing on developing and commercializing vaccines against infectious diseases. With a strong pipeline of vaccine candidates, including potential COVID-19 vaccines, Valneva aims to address global healthcare challenges and improve public health. As a leader in the vaccine industry, the company remains committed to innovation and delivering safe and effective vaccines to the market.
